Detalhe da pesquisa
1.
Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease.
Am J Gastroenterol
; 119(2): 306-312, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737675
2.
Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's disease.
Gastrointest Endosc
; 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38462057
3.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594435
4.
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study.
Clin Gastroenterol Hepatol
; 21(1): 182-191.e2, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644343
5.
Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life.
Gut
; 70(7): 1266-1274, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046558
6.
Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease.
Int J Behav Med
; 26(4): 415-426, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31183787
7.
High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
Dig Dis Sci
; 62(2): 465-472, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27933473
8.
Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial.
Gastroenterology
; 149(1): 130-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25790742
9.
Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study.
Inflamm Bowel Dis
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38666643
10.
Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn's disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy.
Eur J Gastroenterol Hepatol
; 35(1): 45-51, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468568
11.
Impact of timing of primary ileocecal resection on prognosis in patients with Crohn's disease.
BJS Open
; 7(5)2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772836
12.
Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry.
Aliment Pharmacol Ther
; 57(1): 117-126, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282200
13.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(4): 343-355, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736339
14.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
J Crohns Colitis
; 17(11): 1771-1780, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310877
15.
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study.
J Gastrointestin Liver Dis
; 31(1): 18-24, 2022 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306553
16.
Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
Inflamm Bowel Dis
; 28(Suppl 2): S16-S24, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969091
17.
Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn's disease.
Eur J Gastroenterol Hepatol
; 34(10): 983-992, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062493
18.
Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.
J Crohns Colitis
; 15(11): 1920-1930, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909062
19.
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
J Crohns Colitis
; 15(4): 529-539, 2021 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079178
20.
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study.
Aliment Pharmacol Ther
; 52(8): 1366-1376, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32901983